Central airway administration for systemic delivery of therapeutics
Details for Australian Patent Application No. 2002316574 (hide)
International Classifications
Event Publications
9 January 2003 Complete Application Filed
Priority application(s): 60/364,482 15.03.02 US
6 November 2003 Application Open to Public Inspection
Published as AU-B-2002316574
30 June 2005 Amendment Made
The nature of the amendment is: Amend the name of the applicant/patentee from The Brigham and Women's Hospital, Inc. to The Brigham and Women's Hospital, Inc., Children's Medical Center Corporation, Syntonix Pharmaceuticals, Inc., Brandeis University
1 May 2008 Application Accepted
Published as AU-B-2002316574
28 August 2008 Standard Patent Sealed
2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002316575-MICROORGANISMS AND PROCESSES FOR ENHANCED PRODUCTION OF PANTOTHENATE
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser